The one-person unicorn: Medvi at $401M in sales with two people
A November analysis of solo-founder economics cites Medvi, a telehealth GLP-1 seller built in two months with about a dozen AI tools, booking $401 million in first-year sales with two people and keeping 16.2% as net profit. Base44 reached 250,000 users in six months and sold to Wix for about $80 million. The same piece flags the caveats: an FDA warning letter to Medvi and a support bot that sometimes invented drug prices.